Gobernanza Roche Holding AG

ROG

CH0012032048

Farmacéuticos

Tiempo real estimado Cboe Europe Otros sitios de cotización 16:00:10 11/09/2024			Varia. Cinco días.	Varia. 1 de enero.
269,15 ^CHF	+0,09 %		-3,04 %	+10,72 %

08:00	Bolsa de Madrid: El estado de ánimo es cada vez más pesado, pero Taylor Swift vigila
10/09	El mercado de la pérdida de peso verá 16 nuevos fármacos en 2029, según un informe	RE

Comité Ejecutivo: Roche Holding AG

Director

Funciones ocupadasDesde

Thomas Schinecker

49 años

Chief Executive Officer

15/03/2023

Levi Garraway

Chief Tech/Sci/R&D Officer

Pascale Schmidt

51 años

Compliance Officer

01/01/2020

Claudia Boeckstiegel

60 años

General Counsel

01/04/2020

Annette Luther

54 años

Corporate Secretary

01/04/2020

Alan Hippe

57 años

Chief Tech/Sci/R&D Officer	07/09/2011
Director of Finance/CFO	06/06/2011

Cristina A. Wilbur

57 años

Human Resources Officer

Bruno Eschli

Investor Relations Contact

Composición del Consejo de Administración: Roche Holding AG

Administrador

ComitésDesde

Severin Schwan

57 años

Executive Committee

01/01/2013

André S. Hoffmann

66 años

Governance Committee	01/01/1996
Nominating Committee	01/01/1996
Compensation Committee Chair	08/04/2013
Governance Committee Chair	01/01/1996

Claudia Dyckerhoff

58 años

Governance Committee	01/03/2016
Compensation Committee	21/04/2016

Anita Hauser

55 años

Compensation Committee	01/01/2007
Governance Committee	14/03/2017

Ulf Mark Schneider

59 años

Audit Committee	01/10/2014
Governance Committee	01/10/2014

Bernard Poussot

72 años

Compensation Committee

01/01/2015

Joerg Duschmale

40 años

Audit Committee

17/03/2020

Patrick Frost

56 años

Audit Committee

17/03/2020

Richard P. Lifton

71 años

Director/Board Member	03/03/2015
Independent Dir/Board Member	03/03/2015

Jemilah Mahmood

Director/Board Member

Akiko Iwasaki

Director/Board Member

Últimos Nombramientos: Roche Holding AG

Page Industries Limited anuncia un cambio en la Dirección	08/08	CI
JW (Caimán) Therapeutics Co. Ltd anuncia cambios en su director general	31/07	CI
Zealand Pharma nombra director comercial	30/07	MT
Immunic, Inc. nombra a Simona Skerjanec miembro del consejo de administración	24/07	CI
Nkarta, Inc. nombra a George Vratsanos miembro del consejo de administración	13/06	CI
Roche anuncia cambios en la dirección y en los comités del Consejo	27/05	CI
Roche, tercera empresa más sostenible en el índice farmacéutico de Dow Jones	15/12	MT

Más noticias

Antiguos Directivos y Administradores: Roche Holding AG

Insider

Funciones ocupadas

DesdeHasta

Christoph Franz

Chairman	01/03/2014	15/03/2023
Independent Dir/Board Member	01/03/2014	15/03/2023

Julie Brown

Director/Board Member	01/03/2016	26/09/2022
Independent Dir/Board Member	01/03/2016	26/09/2022

William Pao

Corporate Officer/Principal

01/05/2014

18/03/2022

Paul Bulcke

Director/Board Member	06/06/2011	01/01/2022
Independent Dir/Board Member	06/09/2011	15/03/2012

Gottlieb A. Keller

General Counsel	13/01/2010	31/03/2020
Corporate Secretary	01/01/2008	31/03/2020

John Bell

Director/Board Member	17/09/2009	17/03/2020
Independent Dir/Board Member	01/04/2011	12/09/2011
Corporate Officer/Principal	01/01/2001	17/09/2009

Andreas Oeri

Director/Board Member	13/01/2010	17/03/2020
Independent Dir/Board Member	06/09/2011	17/03/2020
Corporate Officer/Principal	01/01/1996	13/01/2010

Stephan Feldhaus

Public Communications Contact

08/09/2010

30/09/2019

Peter Voser

Director/Board Member	01/02/2011	30/06/2019
Independent Dir/Board Member	06/09/2011	15/03/2012

John Reed

Corporate Officer/Principal

02/04/2013

02/04/2018

Roland Diggelmann

Corporate Officer/Principal

01/01/2012

01/01/2018

Pius Baschera

Director/Board Member	13/01/2010	31/03/2017
Independent Dir/Board Member	06/09/2011	12/09/2011

DeAnne Shirley Julius

Director/Board Member	13/01/2010	01/03/2016
Independent Dir/Board Member	06/09/2011	01/03/2016
Corporate Officer/Principal	01/01/2002	13/01/2010

Beatrice Weder di Mauro

Director/Board Member	13/01/2010	01/03/2016
Independent Dir/Board Member	29/07/2011	12/09/2011

Silvia Ayyoubi

Human Resources Officer

13/01/2010

31/12/2015

Hyam Levitsky

Corporate Officer/Principal

01/08/2011

01/02/2015

Michael Varney

Corporate Officer/Principal

01/01/2015

Richard Scheller

Corporate Officer/Principal

01/01/2009

31/12/2014

William Burns

Director/Board Member	01/03/2010	04/03/2014
Independent Dir/Board Member	01/03/2010	15/03/2012

Franz Humer

Chairman

06/09/2011

04/03/2014

Bruno Gehrig

Director/Board Member	01/01/2004	05/03/2013
Independent Dir/Board Member	01/01/2004	15/03/2012

Lodewijk J. R. de Vink

Director/Board Member	13/01/2010	05/03/2013
Independent Dir/Board Member	11/04/2011	12/09/2011
Corporate Officer/Principal	01/01/2004	13/01/2010

Jean-Jacques Garaud

Corporate Officer/Principal

01/01/2007

30/06/2012

Klaus Gustav Strein

Corporate Officer/Principal

14/09/2011

Erich Hunziker

Director/Board Member	18/01/2011	18/01/2011
Chief Tech/Sci/R&D Officer	13/01/2010	31/03/2011
Director of Finance/CFO	01/10/2001	31/03/2011

Wolfgang Ruttenstorfer

Director/Board Member	13/01/2010	14/12/2010
Independent Dir/Board Member	01/01/2007	01/01/2011

Walter Frey

Director/Board Member	13/01/2010	14/12/2010
Independent Dir/Board Member	01/01/2001	01/01/2011
Corporate Officer/Principal	01/01/2001	13/01/2010

David M. Goldstein

Corporate Officer/Principal

01/01/1994

01/01/2011

Peter Brabeck-Letmathe

Director/Board Member

01/03/2010

Arthur Levinson

Director/Board Member	01/03/2010	-
Independent Dir/Board Member	26/04/2011	12/09/2011

Per-Olof Attinger

Corporate Officer/Principal

01/01/2010

Eduard Enrico Holdener

Corporate Officer/Principal

01/01/1995

01/01/2007

Michael Burgess

Corporate Officer/Principal

24/10/2011

Rolf Hänggi

Director/Board Member

01/01/2006

Dirk W. Kirsten

Corporate Officer/Principal

01/01/2002

01/01/2004

Domenico Scala

Corporate Officer/Principal	01/01/1995	01/01/2000
Treasurer	01/01/2000	01/01/2003

Henri-Paul Meier

Investor Relations Contact	09/09/2011	-
Public Communications Contact	15/03/2002	-

Horst Teltschik

Director/Board Member	13/01/2010	-
Corporate Officer/Principal	01/01/2002	13/01/2010

Anton Affentranger

Director of Finance/CFO

Jürg Witmer

Public Communications Contact

01/01/1978

Vincent Charlon

Corporate Officer/Principal

01/01/1990

01/01/1998

Unni Hjelmaas

Corporate Officer/Principal

01/01/1997

Rolf Schläpfer

Public Communications Contact

01/01/1997

Gerard Farmer

General Counsel

01/01/1989

Pierre Jaccoud

Corporate Secretary

01/01/1988

Eva Losert

Public Communications Contact

Daniel O'Day

Corporate Officer/Principal

Peter Boyle

Investor Relations Contact

Melanie Wolf

Public Communications Contact

Wing-Kai Chan

Corporate Officer/Principal

Ashok Dhanrajgir

Corporate Officer/Principal

Markus Hosang

Corporate Officer/Principal

Simon Roitt

Corporate Officer/Principal

Ivan Melezínek

Corporate Officer/Principal

Tom Edward Pike

Corporate Officer/Principal

Marc Salzberg

Corporate Officer/Principal

Kuno Sommer

Corporate Officer/Principal

Alexander Klauser

Public Communications Contact

08/09/2010

Andreas Greuter

General Counsel

Urs Jaisli

Compliance Officer

31/01/2013

Tim George

Sales & Marketing

Dámaso Molero

Corporate Officer/Principal

Ken A. Brameld

Corporate Officer/Principal

Andreas Emmenegger

Corporate Officer/Principal

Karl Mahler

Investor Relations Contact	-	-
Public Communications Contact	-	-

Peter Johann

Sales & Marketing

Stefan Ryser

Human Resources Officer

Ann Moravick

Corporate Officer/Principal

Robert Salcedo

Corporate Officer/Principal

George Abercrombie

Corporate Officer/Principal

Jean-Pierre Obrecht

Corporate Officer/Principal

Garner William

Corporate Officer/Principal

Fritz Hoffmann-la Roche

Founder

Distribución por Edad de los Ejecutivos

Paridad de género

Hombre	19
Mujer	8

De los cuales Comité Ejecutivo

Hombre	5
Mujer	3

De los cuales Directores

Hombre	10
Mujer	1

ESG Refinitiv

A+

Medio ambiente

Emisiones

Innovación

Utilización de recursos

Gobernanza

Estrategia de RSE

Gestión

Accionistas

Polémica

Roche Holding AG (Roche) es una empresa sanitaria basada en la investigación. Las actividades operativas de la empresa se organizan en dos divisiones: Farmacéutica y Diagnóstica. La División Farmacéutica consta de dos segmentos de negocio: Roche Pharmaceuticals y Chugai. La División Diagnóstica consta de cuatro áreas de negocio: Diabetes Care, Diagnóstico Molecular, Diagnóstico Profesional y Diagnóstico Tisular. La empresa desarrolla medicamentos para diversas áreas de enfermedades, como la oncología, la inmunología, las enfermedades infecciosas, la oftalmología y la neurociencia. Sus productos farmacéuticos incluyen Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin y Roferon-A. La empresa ofrece productos para investigadores, como el análisis celular, la expresión génica, la secuenciación del genoma y la purificación de ácidos nucleicos.

Empleados

103.605

Sector

Farmacéuticos

Agenda

13/09/2024 - European Association for the Study of Diabetes Meeting

Índices relacionados

SMI , STOXX Europe 600 Index (EUR)

Más información sobre la empresa